Zehui Tan

发表

Design, synthesis and antitumor evaluation of ATP dual-mimic 2,4-diarylaminopyrimidine and aminoindazole conjugates as potent anaplastic lymphoma kinase inhibitors.

X. Zhai, Jing Yang, Jiahao Zhang, 2022, European journal of medicinal chemistry.

Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type-I1/2ALK inhibitors with promising antitumor effects.

X. Zhai, Nan Jiang, B. Shao, 2022, Bioorganic & medicinal chemistry letters.

An updated patent review of autotaxin inhibitors (2017–present)

X. Zhai, Ming-juan Guo, Hongrui Lei, 2020, Expert opinion on therapeutic patents.

Discovery of novel tetrahydropyrido[4,3-d]pyrimidine analogs as potent autotaxin regulators with impressive tumor suppression effects

X. Zhai, Fuyi Wang, Nan Jiang, 2022, Journal of Molecular Structure.

Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors.

X. Zhai, Shu-yu Liu, Fuyi Wang, 2022, Bioorganic & medicinal chemistry.

A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus

Howard Xu, Paula King, C. Malone, 2002, Molecular microbiology.

Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer

Jiahao Zhang, Deyi Ma, Zhi Cao, 2024, Acta pharmaceutica Sinica. B.

Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy.

Hongrui Lei, Zehui Tan, Shuyu Liu, 2024, Journal of medicinal chemistry.

An update on allosteric modulators as a promising strategy targeting histone methyltransferase.

X. Zhai, Hongrui Lei, Tongshong Li, 2021, Pharmacological research.